Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

48 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-10-24

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Moyamoya disease is characterized by progressive stenosis of the genesis of the distal internal carotid arteries bilaterally and progressive generation of compensatory pathological vascular networks at the basis cranii, and these pathological vasculature has poor vascular reactivity. Perioperative circulatory management of patients with smoky vessels to ensure perfusion of brain tissue and integrity of brain network during surgery to minimize postoperative impairment of neurological functions, including motor, sensory, emotional and cognitive functions, is the key point of perioperative circulatory management of moyamoya disease. Functional Magnetic Resonance Imaging (fMRI) has been routinely used in various cerebrovascular diseases to further evaluate cerebrovascular reserve and cerebral network connectivity. The purpose of this study is to observe the changes in cerebral blood flow, cerebral oxygen metabolism, cerebral oxygen metabolism rate, and cerebral network connectivity in adult patients with moyamoya disease in cerebral ischemia-sensitive areas under anesthesia to provide a basis for exploring anesthesia management to improve cognitive function and cerebral network connectivity in these patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predicative Value of Multimodal MRI in Moyamoya Disease

NCT03785171

Moyamoya Disease Magnetic Resonance Imaging

UNKNOWN

The Evolution and Prognosis of Moyamoya Disease

NCT05619068

Moyamoya Disease Revascularization Cognitive Impairment +1 more

RECRUITING

Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease

NCT06832839

Moyamoya Disease

RECRUITING

Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients

NCT06330818

Moyamoya Disease Moyamoya

RECRUITING NA

Intracranial Artery Stenosis Magnetic Resonance Imaging: Aetiology and Progression

NCT03417063

Ischemic Stroke Transient Ischemic Attack Intracranial Artery Stenosis

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Moyamoya Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with moyamoya disease scheduled for direct or indirect intracranial and extracranial revascularization surgery
* Age between 18-65 years
* Obtain written informed consent.

Exclusion Criteria

* Patients with preoperative claustrophobia, sensory or motor aphasia that are unable to understand and cooperate with the examination
* Preoperative cranial imaging suggesting cerebral infarction lesion diameter \>15mm
* Patients allergic to anesthetic drugs
* Metal implants in the body
* Undergoing other experimental drug or instrumentation trials

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No